Overnight, pharmaceutical company Pfizer with biotech partner BioNTech announced that the initial phase III trial results have found their COVID-19 vaccine to be “more than 90% effective”.
- Market: International
- Sector: -
10 November 2020
Browsing public site
Overnight, pharmaceutical company Pfizer with biotech partner BioNTech announced that the initial phase III trial results have found their COVID-19 vaccine to be “more than 90% effective”.